Comparison of bioavailability of amorphous versus crystalline itraconazole nanoparticles via pulmonary administration in rats

What is the True Solubility Advantage for Amorphous Pharmaceuticals?

Bruno C. Hancock, Michael Parks · Pharmaceutical Research · 2000 · 1.3K citations

Pharmacy, Pharmaceutical Analysis, Pharmaceutics +14

Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs

Gary G. Liversidge, Kenneth C. Cundy · International Journal of Pharmaceutics · 1995 · 737 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Passage of Intratracheally Instilled Ultrafine Particles from the Lung into the Systemic Circulation in Hamster

Abderrahim Nemmar, H Vanbilloen, Marc Hoylaerts et al. · American Journal of Respiratory and Critical Care Medicine · 2001 · 641 citations

Pharmacy, Pharmacokinetics, Toxicology +17

Research Strategies for Safety Evaluation of Nanomaterials, Part V: Role of Dissolution in Biological Fate and Effects of Nanoscale Particles

Paul J. A. Borm, Frederick C. Klaessig, Timothy D. Landry et al. · Toxicological Sciences · 2006 · 582 citations · Full text

Pharmacy, Materials Science, Toxicology +17

Eudragit RS100® nanosuspensions for the ophthalmic controlled delivery of ibuprofen

Rosario Pignatello, Claudio Bucolo, Piera Ferrara et al. · European Journal of Pharmaceutical Sciences · 2002 · 342 citations

Pharmacy, Pharmaceutics, Pharmacology +14